The DOI matches its Crossref record.
Increased Amygdala Responses to Sad But Not Fearful Faces in Major Depression: Relation to Mood State and Pharmacological Treatment
Abstract
OBJECTIVE: Increased amygdala response to negative emotions seen in functional MRI (fMRI) has been proposed as a biomarker for negative emotion processing bias underlying depressive symptoms and vulnerability to depressive relapse that are normalized by antidepressant drug treatment. The purpose of this study was to determine whether abnormal amygdala responses to face emotions in depression are related to specific emotions or change in response to antidepressant treatment and whether they are present as a stable trait in medication-free patients in remission. METHOD: Sixty-two medication-free unipolar depressed patients (38 were currently depressed, and 24 were in remission) and 54 healthy comparison subjects underwent an indirect face-emotion processing task during fMRI. Thirty-two currently depressed patients were treated with the antidepressant citalopram for 8 weeks. Adherence to treatment was evaluated by measuring citalopram plasma concentrations. RESULTS: Patients with current depression had increased bilateral amygdala responses specific to sad faces relative to healthy comparison subjects and nonmedicated patients in stable remission. Treatment with citalopram abolished the abnormal amygdala responses to sad faces in currently depressed patients but did not alter responses to fearful faces. CONCLUSIONS: Aberrant amygdala activation in response to sad facial emotions is specific to the depressed state and is a potential biomarker for a negative affective bias during a depressive episode.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, enhanced responsiveness to negative emotions, (mediated by enhanced amygdala response), has been observed in non-parent depression (Arnone et al., 2012).”
From Approaching the biology of human parental attachment: Brain imaging, oxytocin and coordinated assessments of mothers and fathers (2014) · cites this paper as Arnone et al., 2012
Citations
Cited by
Sorted by citations
Examining emotion regulation in depression: A review and future directions
Joormann, J., & Stanton, C. H. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.07.007 · Cited by 749
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“5-HT availability (e.g. through chronic selective serotonin reuptake inhibitors (SSRIs)) but postsynaptic 5-HT1ARs do not (Lanfumey and Hamon, 2000), although they do appear to downregulate in response to stress (Berton et al., 1998; Lopez et al., 1999) – and perhaps relatedly, to electroconvulsive shock (Burnet et al…”
BackgroundInfluentialPrecision psychiatry: a neural circuit taxonomy for depression and anxiety
Williams, L. M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00579-9 · Cited by 641
Cognitive function following a major depressive episode: a systematic review and meta-analysis
Semkovska, M., Quinlivan, L., O'Grady, T., Johnson, R., Collins, A., O'Connor, J., Knittle, H., Ahern, E., & Gload, T. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30291-3 · Cited by 631
Rive, M. M., van Rooijen, G., Veltman, D. J., .Phillips, M. L., Schene, A. H., & Ruhé, H. G. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.07.018 · Cited by 481
“Nevertheless, medication is thought to diminish amygdala activity during passive exposure as well as during regulation of negative emotional stimuli (Anand et al., 2007; Arce et al., 2008; Arnone et al., 2012; de Almeida et al., 2010; Fu et al., 2004; Godlewska et al., 2012; Harmer et al., 2006; Sheline et al., 2001;…”
BackgroundEstrogen, Stress, and Depression: Cognitive and Biological Interactions
Albert, K. M., & NEWHOUSE, P. A. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095557 · Cited by 373
Wise, T., Raduà, J., Nortje, G., Cleare, A. J., Young, A. H., & Arnone, D. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.004 · Cited by 306
“Nevertheless further research investigating the contribution of mood state to neuroimaging findings is warranted as there is very little data available in the literature (46,47).”
BackgroundSelf-citationWilliams, L. M. (2016) · Depression and Anxiety · doi:10.1002/da.22556 · Cited by 302
“In addition to the findings for threat, MDD has also beenassociatedwithmood-congruent hyperreactivity of the amygdala evoked by sad faces (Arnone et al., 2012; Fu et al., 2004; Victor et al., 2010).”
BackgroundSwain, J. E., Kim, P., Spicer, J., Ho, S. S., Dayton, C. J., Elmadih, A., & Abel, K. M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.007 · Cited by 290
“Notably, enhanced responsiveness to negative emotions, (mediated by enhanced amygdala response), has been observed in non-parent depression (Arnone et al., 2012).”
State-dependent changes in hippocampal grey matter in depression
Arnone, D., McKie, S., Elliott, R., Juhasz, G., Thomas, E. J., Downey, D., Williams, S., Deakin, J. F. W., & Anderson, I. M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.150 · Cited by 287
Self-citationPhillips, M. L., Chase, H. W., Sheline, Y. I., Etkin, A., Almeida, J. R. C., Deckersbach, T., & Trivedi, M. H. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010076 · Cited by 267
Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis
Ma, Y. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.24 · Cited by 270
Williams, L. M., Korgaonkar, M. S., Song, Y. C., Paton, R., Eagles, S., Goldstein-Piekarski, A., Grieve, S. M., Harris, A. W. F., Usherwood, T., & Etkin, A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.89 · Cited by 195
“This suggestion is consistent with previous evidence that amygdala activation for subliminal sadness in MDD changes following treatment (Victor et al, 2010; Arnone et al, 2012).”
BackgroundMethodResultInfluentialComputational meta‐analysis of statistical parametric maps in major depression
Arnone, D., Job, D. E., Selvaraj, S., Abe, O., Amico, F., Cheng, Y., Colloby, S. J., O'Brien, J. T., Frodl, T., Gotlib, I. H., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23108 · Cited by 189
“Our finding of grey matter loss in hippocampus and parahippocampal gyrus is consistent with Du et al.’s [2012] results and represents the most frequently replicated morphometric abnormality in major depression [Arnone et al., 2012a; Koolschijn et al., 2009; Schmaal et al., 2015].”
BackgroundMethodResultInfluentialSelf-citationConnolly, C. G., Ho, T. C., Blom, E. H., LeWinn, K. Z., Sacchet, M. D., Tymofiyeva, O., Simmons, A. N., & Yang, T. T. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.026 · Cited by 177
“…activation to emotional stimuli has also been associated with successful pharmacological and psychotherapeutic interventions for depression in both adults (Arnone et al., 2012; Fu et al., 2008; Godlewska et al., 2012; Sheline et al., 2001) and adolescents (Straub et al., 2015; Tao et al., 2012).”
BackgroundNeuropsychiatric syndromes of multiple sclerosis
Murphy, R., O’Donoghue, S., Counihan, T. J., McDonald, C., Calabresi, P. A., Ahmed, M. A., Kaplin, A. I., & Hallahan, B. P. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-315367 · Cited by 182
Insomnia Disorder is Associated with Increased Amygdala Reactivity to Insomnia-Related Stimuli
Baglioni, C., Spiegelhalder, K., Regen, W., Feige, B., Nissen, C., Lombardo, C., Violani, C., Hennig, J., & Riemann, D. W. (2014) · SLEEP · doi:10.5665/sleep.4240 · Cited by 175
Neuronal connectivity in major depressive disorder: a systematic review
Helm, K., Viol, K., Weiger, T. M., Tass, P. A., Grefkes, C., del Monte, D., & Schiepek, G. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s170989 · Cited by 164
Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder
Korgaonkar, M. S., Williams, L. M., Song, Y. J. C., Usherwood, T. P., & Grieve, S. M. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.140376 · Cited by 147
Jung, J., Kang, J. C., Won, E., Nam, K., Lee, M.-S., Tae, W., & Ham, B. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.08.018 · Cited by 133
“The pathology of MDD is still unclear but it has been agreed that a distributed brain network involved in mood regulation is structurally and functionally impaired by MDD (Mayberg, 1997; Drevets et al., 2007, 2008; Arnone et al., 2012a; Lai and Wu, 2014).”
BackgroundJust, S., Chenard, B. L., Ceci, A., Strassmaier, T., Chong, J. A., Blair, N. T., Gallaschun, R. J., del Camino, D., Cantin, S., D’Amours, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191225 · Cited by 137
In Search of Neural Endophenotypes of Postpartum Psychopathology and Disrupted Maternal Caregiving
Moses‐Kolko, E. L., Horner, M. S., Phillips, M. L., Hipwell, A. E., & Swain, J. E. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12183 · Cited by 134
Sankar, A., Melin, A., Lorenzetti, V., Horton, P., Costafreda, S. G., & Fu, C. H. Y. (2018) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2018.07.002 · Cited by 114
Redlich, R., Opel, N., Bürger, C., Dohm, K., Grotegerd, D., Förster, K., Zaremba, D., Meinert, S. L., Repple, J., Enneking, V., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.246 · Cited by 111
Biomarkers for major depressive disorder
Hacımusalar, Y., & Eşel, E. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2017.19482 · Cited by 123
Schulze, L., Schulze, A., Renneberg, B., Schmahl, C., & Niedtfeld, I. (2019) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.11.004 · Cited by 102
Diagnostic and therapeutic utility of neuroimaging in depression: an overview
Arnone, D., Wise, T., Cleare, A. J., Young, A. H., & Herane-Vives, A. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s50156 · Cited by 106
“Amygdala hyperactivity in response to negative emotions has been demonstrated to be characteristic of a depressed state and is sensitive to clinical improvement after a course of antidepressant treatment.(46) These findings suggest that structural and functional neuroimaging could contribute to the prediction of treat…”
Self-citationAn affective neuroscience model of boosting resilience in adults
Tabibnia, G. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.005 · Cited by 115
Functional MRI findings, pharmacological treatment in major depression and clinical response
Arnone, D. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.004 · Cited by 102
Self-citationZisner, A. R., & Beauchaine, T. P. (2016) · Development and Psychopathology · doi:10.1017/s0954579416000754 · Cited by 101
An fMRI study of emotional face processing in adolescent major depression
Hall, L. M. J., Klimes‐Dougan, B., Hunt, R. H., Thomas, K. M., Houri, A. K., Noack, E., Mueller, B. A., Lim, K. O., & Cullen, K. R. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.037 · Cited by 92
Hastings, P. D., Klimes-Dougan, B., Kendziora, K. T., Brand, A., & Zahn-Waxler, C. (2014) · Development and Psychopathology · doi:10.1017/s0954579414001084 · Cited by 87
“It was intriguing that a recent neuroimaging study revealed that unipolar depressed patients showed elevated bilateral amygdala response to sad faces but not fearful faces (Arnone et al., 2012), which also suggests that depression is characterized by strong neurobiological arousal specifically by sad stimuli.”
BackgroundFunctional MRI in major depressive disorder: A review of findings, limitations, and future prospects
Pilmeyer, J., Huijbers, W., Lamerichs, R. M. J. N., Jansen, J. F. A., Breeuwer, M. M., & Zinger, S. (2022) · Journal of Neuroimaging · doi:10.1111/jon.13011 · Cited by 94
Fu, C. H. Y., Costafreda, S. G., Sankar, A., Adams, T. M., Rasenick, M. M., Liu, P., Donati, R. J., Maglanoc, L. A., Horton, P., & Marangell, L. B. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0457-2 · Cited by 86
“Furthermore, most studies to date have examined the effects of the SRI class of antidepressants [3-5,34].”
BackgroundResultWang, L., Zhao, Y., Edmiston, E. K., Womer, F. Y., Zhang, R., Zhao, P., Jiang, X., Wu, F., Kong, L., Zhou, Y., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00923 · Cited by 81
Barraclough, M. L., McKie, S., Parker, B., Jackson, A., Pemberton, P. W., Elliott, R., & Bruce, I. N. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214677 · Cited by 78
Self-citationA two-factor model of relapse/recurrence vulnerability in unipolar depression
Farb, N. A. S., Irving, J. A., Anderson, A. K., & Segal, Z. V. (2015) · Journal of Abnormal Psychology · doi:10.1037/abn0000031 · Cited by 75
Zhang, M., Zhou, H., Liu, L., Feng, L., Yang, J., Wang, G., & Zhong, N. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.01.017 · Cited by 75
Default mode network deactivation during emotion processing predicts early antidepressant response
Spies, M., Kraus, C., Geissberger, N., Auer, B., Klöbl, M., Tik, M., Stürkat, I.-L., Hahn, A., Woletz, M., Pfabigan, D. M., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.265 · Cited by 68
Wessa, M., & Lois, G. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150416224801 · Cited by 70
“[24] n =32 MDD n=15 CON open-label study, longitudinal design MADRS=27 (4.”
BackgroundThe neuroscience of depression: Implications for assessment and intervention
Singh, M. K., & Gotlib, I. H. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.08.008 · Cited by 75
“Other studies suggest that aberrant amygdala activation in response to sad faces (Arnone et al., 2012) and memory formation and retrieval (van Wingen et al., 2010) are specific to the depressed state and are responsive to treatment.”
Outhred, T., Hawkshead, B. E., Wager, T. D., Das, P., Malhi, G. S., & Kemp, A. H. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.07.010 · Cited by 70
Deficits of unconscious emotional processing in patients with major depression: An ERP study
Zhang, D., He, Z., Chen, Y., & Wei, Z. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.056 · Cited by 66
Social-economical decision making in current and remitted major depression
Pulcu, E., Thomas, E. J., Trotter, P. D., McFarquhar, M., Juhasz, G., Sahakian, B. J., Deakin, J. F. W., Anderson, I. M., Zahn, R., & Elliott, R. (2015) · Psychological Medicine · doi:10.1017/s0033291714002414 · Cited by 62
“It is notable that combining UG offers with emotive pictures of proposers in studies of depressed individuals may be further complicated by differences in facial emotion recognition in MDD (Anderson et al. 2011; Arnone et al. 2012).”
BackgroundSelf-citationGünther, V., Dannlowski, U., Kersting, A., & Suslow, T. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0501-2 · Cited by 65
“Studies using neuroimaging techniques revealed a hyper-responsiveness of the amygdala to negative stimuli in patients suffering from MDD [27–31].”
MethodWeightman, M. J., Knight, M. J., & Baune, B. T. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.02.035 · Cited by 74
“, 2004), citalopram (Arnone et al., 2012), sertraline (Victor et al.”
Modulation of amygdala reactivity following rapidly acting interventions for major depression
Loureiro, J. R., Leaver, A. M., Vasavada, M. M., Sahib, A. K., Kubicki, A., Joshi, S. H., Woods, R. P., Wade, B., Congdon, E. L., Espinoza, R. T., et al. (2020) · Human Brain Mapping · doi:10.1002/hbm.24895 · Cited by 64
Wei, S., Chang, M., Zhang, R., Jiang, X., Wang, F., & Tang, Y. (2018) · Annals of General Psychiatry · doi:10.1186/s12991-018-0208-0 · Cited by 64
Seymour, K. E., Jones, R. N., Cushman, G. K., Galvan, T., Puzia, M., Kim, K. L., Spirito, A., & Dickstein, D. P. (2015) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0733-1 · Cited by 64
Chen, J., Ma, W., Zhang, Y., Wu, X., Wei, D., Liu, G., Deng, Z., Yang, L.-Q., & Zhang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109176 · Cited by 58
“Several neuroimaging studies have also indicated that reduced amygdala activation in response to positive stimuli in depression may be linked to anhedonic symptoms caused by inappropriate salience attribution to positive information [48,49].”
BackgroundIncreased amygdala response to shame in remitted major depressive disorder
Pulcu, E., Lythe, K., Elliott, R., Green, S., Moll, J., Deakin, J. F. W., & Zahn, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086900 · Cited by 57
Self-citationMRI predictors of pharmacotherapy response in major depressive disorder
Gerlach, A. R., Karim, H. T., Peciña, M., Ajilore, O., Taylor, W. D., Butters, M. A., & Andreescu, C. (2022) · NeuroImage: Clinical · doi:10.1016/j.nicl.2022.103157 · Cited by 57
“…regardless of clinical outcome (Victor et al., 2010), similarly outcome-agnostic decreases in amygdala activation to sad but not fearful faces (Arnone, 2012), increases in amygdala activation to subliminal happy and threatening faces for responders and decreases in amygdala activation to…”
BackgroundNeural correlates of successful psychotherapy of depression in adolescents
Straub, J., Plener, P. L., Sproeber, N., Sprenger, L., Kölch, M. G., Groen, G., & Abler, B. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.020 · Cited by 58
Nikolova, Y. S., Misquitta, K. A., Rocco, B. R., Prévot, T. D., Knodt, A. R., Ellegood, J., Voineskos, A. N., Lerch, J. P., Hariri, A. R., Sibille, E. L., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0083-5 · Cited by 52
Social cognition in major depressive disorder: A new paradigm?
Billeke, P. B., Boardman, S., & Doraiswamy, P. M. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0147-9 · Cited by 56
An, J., Wang, L., Li, K., Zeng, Y., Su, Y., Jin, Z., Yu, X., & Si, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-10575-9 · Cited by 48
Diagnostic and clinical implications of functional neuroimaging in bipolar disorder
Brooks, J. O., & Vizueta, N. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.05.018 · Cited by 45
Ehrlich, D., Neigh, G. N., Bourke, C. H., Nemeth, C. L., Hazra, R., Ryan, S. J., Rowson, S. A., Jairam, N., Sholar, C. R., Rainnie, D. G., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.012 · Cited by 47
“Given that escitalopram may help treat depression via regulation of serotonergic transmission in the amygdala (Arnone et al., 2012; Bigos et al., 2008; Lanzenberger et al., 2012; Rosenblau et al., 2012), we also measured offspring expression of two amygdala serotonin receptors linked to the treatment of depression, 5-…”
BackgroundMethodWilliams, L. M., Goldstein‐Piekarski, A. N., Chowdhry, N., Grisanzio, K. A., Haug, N. A., Samara, Z., Etkin, A., O'Hara, R. M., Schatzberg, A. F., Suppes, T. M., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0771-3 · Cited by 46
“who go on to respond to typical first-line antidepressants [27, 29].”
BackgroundWhite Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study
Davis, A. D., Hassel, S., Arnott, S. R., Harris, J. K., Lam, R. W. M., Milev, R. V., Rotzinger, S., Zamyadi, M., Frey, B. N., Minuzzi, L., et al. (2019) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.05.016 · Cited by 46
Grieve, S. M., Korgaonkar, M. S., Etkin, A., Harris, A., Koslow, S. H., Wisniewski, S., Schatzberg, A. F., Nemeroff, C. B., Gordon, E., & Williams, L. M. (2013) · Trials · doi:10.1186/1745-6215-14-224 · Cited by 44
“The rationale behind the use of three treatment arms in iSPOT-D is to identify what are the unique and common brain circuits that modulate response and remission to different types of anti-depressant medications, that is, selective serotonin reuptake inhibitors (SSRIs) versus selective norepinephrine reuptake inhibito…”
BackgroundImaging predictors of remission to anti-depressant medications in major depressive disorder
Kee, F., Korgaonkar, M. S., & Grieve, S. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.002 · Cited by 45
Kleyn, C. E., Talbot, P. S., Mehta, N. N., Sampogna, F., Bundy, C., Ashcroft, D. M., Kimball, A. B., Kerkhof, P., Griffiths, C. E. M., Valenzuela, F., et al. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3375 · Cited by 46
“Functional magnetic resonance imaging (fMRI) shows the amygdala is overly active in people with MDD when shown sad stimuli, but under-active when shown positive stimuli (18), suggesting a neural basis for the negative cognitive bias in MDD which is the therapeutic target of cognitive behavioural therapy.”
BackgroundZhang, R., Zhang, L., Wei, S., Wang, P., Jiang, X., Tang, Y., & Wang, F. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.585664 · Cited by 42
“A recent fMRI study also indicated that suicide attempters exhibited higher brain activity in multiple regions, including the right inferior parietal lobe and left precuneus (Cao et al., 2015).”
BackgroundInfluentialJenkins, L. M., Kendall, A. D., Kassel, M. T., Patrón, V. G., Gowins, J. R., Dion, C., Shankman, S. A., Weisenbach, S. L., Maki, P. M., & Langenecker, S. A. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.027 · Cited by 38
“Notably, other studies have shown that amygdala hyperactivation normalizes with antidepressant treatment (Arnone et al., 2012; Sheline et al., 2001).”
BackgroundFu, C. H. Y., Yong Fan, A., & Davatzikos, C. A. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101997 · Cited by 41
“, 2008b) as well as treatment with a selective serotonin reuptake inhibitor antidepressant (Fu et al., 2004; Arnone et al., 2012) has been associated with nor-”
Depressogenic Thinking and Shame Proneness in the Development of Internalizing Problems
Mills, R. S. L., Hastings, P. D., Serbin, L. A., Stack, D. M., Abela, J. R. Z., Arbeau, K. A., & Lall, D. I. K. (2013) · Child Psychiatry & Human Development · doi:10.1007/s10578-013-0416-4 · Cited by 37
“For example, there is recent neurobiological evidence that depression involves an affective bias specifically involving sadness, as seen in unipolar depressed patients’ elevated bilateral amygdala response to sad faces, but not fearful faces [13].”
BackgroundNeuroimaging for precision medicine in psychiatry
Williams, L. M., & Whitfield, S. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01917-z · Cited by 42
Wu, X., Chen, J., Jia, T., Ma, W., Zhang, Y., Deng, Z., & Yang, L.-Q. (2015) · Brain Topography · doi:10.1007/s10548-015-0444-4 · Cited by 33
“Furthermore, evidence from neuroimaging studies in depression have also demonstrated that decreased amygdala activation in response to positive stimuli may be associated with anhedonic symptoms caused by inappropriate salience attribution to positive information (Arnone et al. 2012; Stuhrmann et al. 2013).”
BackgroundTassone, V. K., Demchenko, I., Salvo, J. J., Mahmood, R., Passa, A.-M. D., Kuburi, S., Rueda, A., & Bhat, V. (2022) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2022.111517 · Cited by 33
Lemke, H., Probst, S., Warneke, A., Waltemate, L., Winter, A., Thiel, K., Meinert, S., Enneking, V., Breuer, F., Klug, M., et al. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.05.008 · Cited by 30
Flournoy, J. C., Bryce, N. V., Dennison, M., Rodman, A. M., McNeilly, E. A., Lurie, L. A., Bitrán, D., Reid-Russell, A., Bustamante, C. M. V., Madhyastha, T. M., et al. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120503 · Cited by 37
“…each fluctuate dynamically within individuals over time and have been associated with neural responses to aversive cues in between-person studies (Arnone et al., 2012; Goldstein-Piekarski et al., 2015; Larson and Ham, 1993; Mroczek and Almeida, 2004; Sliwinski et al., 2009; Swartz et al., 2015b,…”
Neuronal Circuits for Social Decision-Making and Their Clinical Implications
Báez-Mendoza, R., Vázquez, Y., Mastrobattista, E. P., & Williams, Z. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.720294 · Cited by 34
Albert, K. M., Gau, V., Taylor, W. D., & NEWHOUSE, P. A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.010 · Cited by 31
Studies on the animal model of post-stroke depression and application of antipsychotic aripiprazole
Kim, Y. R., Kim, H. N., Pak, M. E., Ahn, S., Hong, K. H., Shin, H. K., & Choi, B. T. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.062 · Cited by 31
Zhang, Z., Huang, P., Li, S., Liu, Z., Zhang, J., Li, Y., & Liu, Z. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114598 · Cited by 30
Szczepanik, J. E., Nugent, A. C., Drevets, W. C., Khanna, A., Zarate, C. A., & Furey, M. L. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.06.005 · Cited by 32
Scopolamine and Depression: A Role for Muscarinic Antagonism?
Hasselmann, H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140618105710 · Cited by 28
Brain mechanisms underlying the emotion processing bias in treatment-resistant depression
Fan, X., Mocchi, M. M., Pascuzzi, B., Xiao, J., Metzger, B. A., Mathura, R. K., Hacker, C. D., Adkinson, J. A., Bartoli, E., Elhassa, S., et al. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00238-w · Cited by 27
“The biased processing of emotional stimuli in depression has been linked to dysfunction in the amygdala 8,9 , the prefrontal cortex (PFC) 10,11 , the dorsal anterior cingulate 12,13 and their connections 14,15 .”
Tassone, V. K., Nezhad, F. G., Demchenko, I., Rueda, A., & Bhat, V. (2024) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2023.111777 · Cited by 30
Horáček, J., Mikoláš, P., Tintěra, J., Novák, T., Páleníček, T., Brunovský, M., Höschl, C., & Alda, M. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140044 · Cited by 27
Neural origins of psychosocial functioning impairments in major depression
Pulcu, E., & Elliott, R. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00237-0 · Cited by 26
Self-citationDecision-Making Dysfunctions of Counterfactuals in Depression: Who Might I have Been?
Howlett, J. R., & Paulus, M. P. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00143 · Cited by 29
TOMM40 rs2075650 May Represent a New Candidate Gene for Vulnerability to Major Depressive Disorder
McFarquhar, M., Elliott, R., McKie, S., Thomas, E., Downey, D., Mekli, K., Toth, Z. G., Anderson, I. M., Deakin, J. F. W., & Juhász, G. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.22 · Cited by 27
Self-citationLuo, L., Becker, B., Zheng, X., Zhao, Z., Xu, X., Zhou, F., Wang, J., Kou, J., Dai, J., & Kendrick, K. M. (2017) · Human Brain Mapping · doi:10.1002/hbm.23880 · Cited by 24
“Most previous patient-based studies showed an opposite pattern, suggesting that MDD patients are more sensitive to sad faces (Arnone et al., 2012; Surguladze et al., 2005) while SAD patients are more sensitive to fearful faces (Frick, Howner, Fischer, Kristiansson, & Furmark, 2013; Killgore and Yurgelun-Todd, 2005).”
ResultChen, Y.-T., Huang, M.-W., Hung, I.-C., Lane, H.-Y., & Hou, C.-J. (2014) · Behavioral and Brain Functions · doi:10.1186/1744-9081-10-36 · Cited by 24
“showed that aberrant amygdala activation in response to sad facial emotions was specific to the depressed state, making it a potential biomarker for negative affective bias during a depressive episode [30].”
BackgroundLucifora, C., Grasso, G. M., Nitsche, M. A., D'Italia, G., Sortino, M., Salehinejad, M. A., Falzone, A., Avenanti, A., & Vicario, C. M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.033 · Cited by 26
Wei, S., Womer, F. Y., Geng, H., Jiang, X., Zhou, Q., Chang, M., Zhou, Y., Tang, Y., & Wang, F. (2017) · Scientific Reports · doi:10.1038/srep44316 · Cited by 24
Atkinson, L. Z., Sankar, A., Adams, T. M., & Fu, C. H. Y. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0022-5 · Cited by 23
Brain-derived neurotrophic factor association with amygdala response in major depressive disorder
Lorenzetti, V., Costafreda, S. G., Rimmer, R. M., Rasenick, M. M., Marangell, L. B., & Fu, C. H. Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.159 · Cited by 20
“Amygdala responsivity is a potential marker of depressive state which shows a demonstrated specificity to sad faces with increased activation during a current depressive episode that normalises following treatment (Fu et al., 2004; Arnone et al., 2012).”
BackgroundNeuroimaging in Psychiatric Pharmacogenetics Research: The Promise and Pitfalls
Falcone, M., Smith, R. M., Chenoweth, M. J., Bhattacharjee, A. K., Kelsoe, J. R., Tyndale, R. F., & Lerman, C. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.152 · Cited by 21
Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials
Zilcha-Mano, S., Wang, Z., Peterson, B. S., Wall, M. M., Chen, Y., Wager, T. D., Brown, P. J., Roose, S. P., & Rutherford, B. R. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.05.023 · Cited by 21
Changes in brain function during negative emotion processing in the long-term course of depression
Enneking, V., Klug, M., Borgers, T., Dohm, K., Grotegerd, D., Frankenberger, L. M., Hülsmann, C., Lemke, H., Meinert, S. L., Leehr, E. J., et al. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.223 · Cited by 20
Fu, C. H. Y., Erus, G., Yong Fan, A., Antoniades, M., Arnone, D., Arnott, S. R., Chen, T., Choi, K. S., Fatt, C. C., Frey, B. N., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04509-7 · Cited by 24
“Treatment protocol was an 8-week trial of SSRI, citalopram, with MRI scans acquired at baseline and week 8 in both MDD and healthy participants [54].”
MethodSelf-citationSpies, M., Klöbl, M., Höflich, A. S., Hummer, A., Vanicek, T., Michenthaler, P., Kranz, G. S., Hahn, A., Winkler, D., Windischberger, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46702-x · Cited by 22
Ai, H., Opmeer, E. M., Marsman, J.-B. C., Veltman, D. J., van der Wee, N. J. A., Aleman, A., & van Tol, M. (2019) · Psychological Medicine · doi:10.1017/s0033291719001259 · Cited by 18
“At the same time, volumetric changes in the hippocampus have 305 been linked to symptomatic improvement following treatment (Arnone et al 2012a), suggesting state-dependency of 306 hippocampal volume.”
BackgroundGeller, W. N., Liu, K., & Warren, S. L. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111349 · Cited by 18
Zeng, J., Wang, Z., Zhang, X., Zhao, A., Qi, H., Jiang, Y., Cai, D., & Zeng, N. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156927 · Cited by 21
fMRI Response of Parietal Brain Areas to Sad Facial Stimuli in Mild Depression
Мельников, М. Е., Петровский, Е. Д., Bezmaternykh, D. D., Kozlova, L. I., Shtark, M. B., Savelov, A. A., Shubina, O. S., & Natarova, K. A. (2018) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-018-4255-y · Cited by 18
Ao, X., Mo, L., Wei, Z., Yu, W., Zhou, F., & Zhang, D. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.593010 · Cited by 20
“…are consistent with previous behavioral findings in depression (Gotlib et al., 1988; Mogg et al., 1991; Koster et al., 2005; Kellough et al., 2008; Atchley et al., 2012; for reviews see Peckham et al., 2010; Winer and Salem, 2016) but also restrict the attentional impairment within the P1 time…”
Result
Metadata
- Authors
- Arnone, D., McKie, S., Elliott, R., Thomas, E. J., Downey, D., Juhasz, G., Williams, S. R., Deakin, J. F. W., & Anderson, I. M.
- Affiliations
- University of Manchester (GB)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2012-08
- Volume
- 169
- Issue
- 8
- Pages
- 841-850
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2057953148
- Cited by
- 192
- References
- 0
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 13 · 2023: 3 · 2022: 11 · 2021: 34 · 2020: 9 · 2019: 15 · 2018: 15 · 2017: 12 · 2016: 14 · 2015: 20 · 2014: 19 · 2013: 11 · 2012: 3
- FWCI
- 22.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- major depressive disorder, amygdala, sad faces, fearful faces, citalopram, antidepressant treatment, remission, mood states, biomarkers, medication adherence
- MeSH terms
- Adult, Affect, Amygdala, Major Depressive Disorder, Depressive Disorder, Major, Facial Expression, Fear, Female, Humans, Magnetic Resonance Imaging, Male, Citalopram, Biomarkers, Case-Control Studies, Antidepressive Agents, Second-Generation, Functional Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review